IBEX 3520.041,90▲ +0,81%EuroStoxx 506485,67▲ +0,95%S&P 5007711,76▼ -0,25%€/$1,1596▲ +0,08%Brent90,18▲ +2,36%Bitcoin66.957▼ -0,13%

Breaking

Velle Capital launches Aude to finance complex real estate operationsMenorca positions itself as a high-end culinary destinationSturzenegger admits decline in formal employment and points to monotributoFormal employment falls in Argentina as monotributo growsATE demands ANSES to reopen salary negotiations and threatens with strikesThe ECB is considering moving bank money to the blockchain

Outlook Therapeutics

Latest Outlook Therapeutics news

2 articles

Primer plano de un frasco de colirio oftalmológico con un calendario borroso al fondo

Companies

Outlook Therapeutics: FDA to Decide on Eye Drug Lytenava on July 29

Outlook Therapeutics faces a pivotal July: shareholders vote on capital increase on the 16th and FDA decides on Lytenava on the 29th.

Beatriz Lorenzo Aguirre · 12 July 2026

Vial of medication on legal documents with a judge's gavel beside it, in a dimly lit boardroom

Companies

Outlook Therapeutics Faces a Decisive July Between the FDA and Capital Dilution

Outlook Therapeutics faces a crucial July: shareholder meeting for capital increase and FDA decision on its flagship drug. Shares rise 144% in 2026.

Beatriz Lorenzo Aguirre · 9 Jul 2026